ADC Payload Summit
Evvnt Promotion / evvnt
21.05.2024 - 23.05.2024 Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 9:00 AM - 6:00 PM
Temi della conferenza
The ADC payload landscape is shifting rapidly. Driven by clinical successes of lower potency topoisomerase I inhibitors and as payloads that elicit novel modes of action continue to gain momentum, ADC developers are looking to harness these payload technologies to diversify the mechanism of action, widen the therapeutic index and expand the disease indications that ADCs can see a benefit in.
The ADC payload landscape is shifting rapidly. Driven by clinical successes of lower potency topoisomerase I inhibitors and as payloads that elicit novel modes of action continue to gain momentum, ADC developers are looking to harness these payload technologies to diversify the mechanism of action, widen the therapeutic index and expand the disease indications that ADCs can see a benefit in.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/2225021-3?pid=4832
Speakers: David Thurstonz, Professor - Drug Discovery, King's College London School of Medicine, Francesca Zammarchi, Chief Scientific Officer, Myricx Bio, and more
Brochure: https://go.evvnt.com/2225021-3?pid=4832
Speakers: David Thurstonz, Professor - Drug Discovery, King's College London School of Medicine, Francesca Zammarchi, Chief Scientific Officer, Myricx Bio, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2225021-2?pid=4832
Ms. Alice Grant
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
